RX Biosyent Inc

Watchlist

15min DelayMarket Closed May 7 16:00 ET

100.39MMarket Cap16.29P/E (TTM)

Biosyent Inc Key Stats

Currency: CAD

Period

Q4 FY2023 Earnings

Mar 13, 2024

Revenue(YoY)

8.27M

+10.88%

EPS(YoY)

0.12

+24.74%

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q2	-- / 8.300M	--
--	2024/Q1	-- / 7.900M	--
Mar 13, 2024	2023/Q4	8.274M / 8.800M	--
Nov 16, 2023	2023/Q3	8.871M / 8.200M	--
Aug 22, 2023	2023/Q2	7.963M / 7.700M	--
May 26, 2023	2023/Q1	6.483M / 7.600M	--
Mar 21, 2023	2022/Q4	7.462M / 6.900M	--
Nov 16, 2022	2022/Q3	6.791M / 7.000M	--
Aug 23, 2022	2022/Q2	6.635M / 7.500M	--
May 18, 2022	2022/Q1	7.037M / 7.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q2-- / 8.300M--

--2024/Q1-- / 7.900M--

Mar 13, 20242023/Q48.274M / 8.800M--

Nov 16, 20232023/Q38.871M / 8.200M--

Aug 22, 20232023/Q27.963M / 7.700M--

May 26, 20232023/Q16.483M / 7.600M--

Mar 21, 20232022/Q47.462M / 6.900M--

Nov 16, 20222022/Q36.791M / 7.000M--

Aug 23, 20222022/Q26.635M / 7.500M--

May 18, 20222022/Q17.037M / 7.000M--

Unlock Free Earnings Estimates

Open Account

Overall